Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Immunoblastic × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

Cyclophosphamide 4 Etoposide 3 Vincristine 2 Rituximab 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Doxorubicin 2 fludarabine phosphate 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Cyclosporine 1 Carmustine 1 Busulfan 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡